Adaptimmune Therapeutics
ADAP
#9424
Rank
โ‚น4.97 B
Marketcap
โ‚น19.32
Share price
-12.60%
Change (1 day)
-82.94%
Change (1 year)

Earnings for Adaptimmune Therapeutics (ADAP)

Earnings in 2024 (TTM): -โ‚น5.62 Billion

According to Adaptimmune Therapeutics's latest financial reports the company's current earnings are โ‚น0.17 Billion. , an increase over its 2023 earnings that were of -โ‚น9.67 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Adaptimmune Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚น5.62 Billion-41.87%
2023 -โ‚น9.67 Billion-30.65%
2022 -โ‚น13.94 Billion-0.36%
2021 -โ‚น13.99 Billion21.62%
2020 -โ‚น11.51 Billion-4.55%
2019 -โ‚น12.06 Billion69%
2018 -โ‚น7.14 Billion-7.47%
2017 -โ‚น7.71 Billion24.71%
2016 -โ‚น6.18 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น13.5 Billion 140.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น0.66 Billion-88.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น21.73 Billion 286.58%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
โ‚น58.77 B-1,145.88%๐Ÿ‡บ๐Ÿ‡ธ USA